期刊文献+

HIV-1 DNA的检测及临床应用

Detection and clinical application of HIV-1 DNA
原文传递
导出
摘要 HIV-1储存库的持续存在是治愈HIV的主要障碍,在临床研究中,需要可靠的生物标志物对其进行标记。HIV-1 DNA在HIV-1储存库中可被持续检测到,在HIV-1感染诊断、预测病毒反弹和监测治疗效果等方面具有重要应用价值。PCR的检测技术是临床上常用的HIV-1 DNA检测方法,随着技术的不断创新与进步,可更准确地通过定性或定量检测感染细胞中总的、整合的和未整合的HIV-1 DNA。感染细胞中不同形式的HIV-1 DNA作为生物标志物在HIV感染监测和艾滋病治疗相关研究中报道日益增多。本文对感染细胞中HIV-1 DNA的检测方法及其作为生物标志物的临床应用进展进行综述。 The persistence of the HIV-1 reservoir is still the main obstacle to the cure of HIV.In clinical research,reliable biomarkers are needed to label it.HIV-1 DNA can be continuously detected in the HIV-1 reservoir.It has significant application value in diagnosing HIV-1 infection,the timing of antiretroviral therapy,the prediction of virus rebound,and monitoring treatment effects.The detection technology based on polymerase chain reaction(PCR)is the most commonly used HIV-1 DNA detection method in clinical practice.The continuous innovation and advancement of technology can accurately detect the total,integrated,and unintegrated HIV-1 DNA in infected cells using qualitative or quantitative methods.Different forms of HIV-1 DNA in infected cells have been increasingly reported as biomarkers in HIV infection monitoring and AIDS treatment-related research.This article reviews the progress of HIV-1 DNA.
作者 董莉娟 陈会超 马艳玲 邢文革 Dong Lijuan;Chen Huichao;Ma Yanling;Xing Wenge(Institute for AIDS/STD Control and Prevention,Yunnan Center for Disease Control and Prevention,Kunming 650022,China;National HIV/AIDS Reference Laboratory,National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China)
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2022年第10期1685-1690,共6页 Chinese Journal of Epidemiology
关键词 艾滋病病毒 脱氧核糖核酸 检测 临床应用 HIV DNA Detection Clinical application
  • 相关文献

参考文献4

二级参考文献22

  • 1Perelson A S, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy[J]. Nature, 1997,387(6629):188-191.
  • 2Natarajan V, Bosehe M, Metcalf J A, et al. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active anfiretroviral therapy[J]. Lancet, 1999,353(9147):119-120.
  • 3Chun T W, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection[J]. Nature,1997,387(6629):183-188.
  • 4Williams S A, Greene W C. Regulation of HIV-1 latency by T-cell active[J]. Cytokine, 2007,39(1):63-74.
  • 5Kariya Y, Kato K, Hayashizaki Y, et al. Revision of consensus sequence of human Alu repeats[J]. Gene, 1987,53(1):1-10.
  • 6Lengauer C, Green E D, Cremer T. Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification[J]. Genomics, 1992,13(3):826-828.
  • 7Pope M, Haase A T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection[J]. Nat Med, 2003,9(7):847-852.
  • 8Fraser C, Ferguson N M, Ghani A C, et al. Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs[J]. AIDS, 2000,14(6):659-669.
  • 9Kitchen S G, Korin Y D, Roth M D, et al. Costimulation of naive of CD8(+) lymphoeytes induces CD4 expression and allows human immunodeficiency virus type 1 infection[J]. J Virology, 1998,72(11):9054-9060.
  • 10画伟,刘志英,魏飞力,张彤,陈德喜,吴昊,焦艳梅.整合型HIV-1检测方法的建立与应用[J].中华检验医学杂志,2009,32(4):387-389. 被引量:5

共引文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部